治疗后缺血病灶演变与卒中患者良好功能结局降低相关
该研究基于MR CLEAN试验数据,纳入226例急性缺血性卒中患者,分析24小时至1周非增强CT上缺血病灶体积变化与功能结局的关联。结果显示,病灶演变中位数为22 mL,每增加10 mL与良好功能结局(mRS≤2)的未调整OR为0.76、调整OR为0.85,成功再通对该关联无显著交互作用。
要点
- 亚急性期缺血病灶演变每增加10 mL,良好功能结局的调整OR为0.85。
- 即使发病24小时后,脑组织损伤仍可持续进展并影响功能结局。
- 成功再通对病灶演变与功能结局的关联无显著交互作用。
核心结论
- 在该研究人群中,亚急性缺血病灶演变与不良功能结局相关。
- 研究提示卒中发病24小时后脑组织损伤仍继续恶化,对功能结局产生负面影响。
- 该发现可能支持在亚急性期追加治疗。
研究设计与样本
- 研究纳入MR CLEAN试验中于卒中发病后24小时和1周接受高质量非增强CT检查的患者。
- 共纳入226例患者,缺血病灶 delineation 包括梗死、水肿和出血转化。
- 病灶演变定义为1周与24小时非增强CT上所测体积之差。
主要发现
- 226例患者中69例(31%)达到良好功能结局。
- 病灶演变中位数为22 mL(四分位距10–45 mL)。
- 病灶演变与良好功能结局显著负相关:未调整OR 0.76(95%CI 0.66–0.86,每10 mL病灶演变,P<0.01)。
- 调整后OR为0.85(95%CI 0.72–0.97,每10 mL病灶演变,P=0.03)。
- 成功再通对病灶演变与良好功能结局的关联无显著交互作用(OR 1.01,95%CI 0.77–1.36,P=0.94)。
关键数值与推荐
- 良好功能结局定义为改良Rankin量表评分≤2。
- 成功再通定义为改良动脉闭塞病变评分3分。
临床怎么用
- 对于急性缺血性卒中患者,发病24小时后仍应关注缺血病灶的演变情况。
- 亚急性期病灶体积增加提示功能结局可能较差,或需考虑追加治疗。
局限性
- 研究基于MR CLEAN试验人群,结论外推需谨慎。
- 原文未报告其他局限性信息。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND AND PURPOSE: Ischemic lesion volume can increase even 24 hours after onset of an acute ischemic stroke. In this study, we investigated the association of lesion evolution with functional outcome and the influence of successful recanalization on this association. METHODS: We included patients from the MR CLEAN trial (Multicenter Randomized Clinical Trial of Endovascular Treatment for Acute Ischemic Stroke in the Netherlands) who received good quality noncontrast CT images 24 hours and 1 week after stroke onset. The ischemic lesion delineations included infarct, edema, and hemorrhagic transformation. Lesion evolution was defined as the difference between the volumes measured on the 1-week and 24-hour noncontrast CTs. The association of lesion evolution with functional outcome was evaluated using unadjusted and adjusted logistic regression. Adjustments were made for baseline, clinical, and imaging parameters that were associated P<0.10) in univariate analysis with favorable functional outcome, defined as modified Rankin Scale score of ≤2. Interaction analysis was performed to evaluate the influence of successful recanalization, defined as modified Arterial Occlusion Lesion score of 3 points, on this association. RESULTS: Of the 226 patients who were included, 69 (31%) patients achieved the favorable functional outcome. Median lesion evolution was 22 (interquartile range, 10–45) mL. Lesion evolution was significantly inversely correlated with favourable functional outcome: unadjusted odds ratio, 0.76 (95% CI, 0.66–0.86; per 10 mL of lesion evolution; P<0.01) and adjusted odds ratio: 0.85 (95% CI, 0.72–0.97; per 10 mL of lesion evolution; P=0.03). There was no significant interaction of successful recanalization on the association of lesion evolution and favorable functional outcome (odds ratio, 1.01 [95% CI, 0.77–1.36]; P=0.94). CONCLUSIONS: In our population, subacute ischemic lesion evolution is associated with unfavorable functional outcome. This study suggests that even 24 hours after onset of stroke, deterioration of the brain continues, which has a negative effect on functional outcome. This finding may warrant additional treatment in the subacute phase.
引用
- Konduri P, van Voorst H, Bucker A, et al. Posttreatment Ischemic Lesion Evolution Is Associated With Reduced Favorable Functional Outcome in Patients With Stroke. Stroke. 2021. PMID: 34289708. doi:10.1161/STROKEAHA.120.032331
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。